ctrl K

Price Alert

Pacific Biosciences of Ca... (PACB)

NASDAQ: PACB · Real-Time Price · USD

1.28

0.05 (4.07%)

At close: Aug 15, 2025, 12:12 PM

Pacific Biosciences of California Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	55.37M	179.91M	325.09M	460.73M
Short-Term Investments	334.56M	451.5M	447.23M	583.67M
Long-Term Investments	n/a	2.42M	n/a	n/a
Other Long-Term Assets	10.84M	13.27M	13.45M	5.76M
Receivables	27.52M	36.62M	18.79M	24.24M
Inventory	58.76M	56.68M	50.38M	24.6M
Other Current Assets	19.47M	3.3M	300K	500K
Total Current Assets	495.68M	742.05M	852.07M	1.1B
Property-Plant & Equipment	46.6M	69.03M	81.34M	79.12M
Goodwill & Intangibles	707.33M	919.25M	820.22M	820.95M
Total Long-Term Assets	764.77M	1B	915.01M	905.84M
Total Assets	1.26B	1.75B	1.77B	2.01B
Account Payables	16.59M	15.06M	12.03M	11M
Deferred Revenue	13.86M	16.34M	30.5M	10.98M
Short-Term Debt	10.03M	490K	1.84M	1.61M
Other Current Liabilities	4.09M	7.84M	175.5M	4.15M
Total Current Liabilities	66.3M	95.03M	263.33M	71.71M
Long-Term Debt	647.49M	892.24M	896.68M	896.07M
Other Long-Term Liabilities	19.25M	20.3M	1.3M	198.24M
Total Long-Term Liabilities	687.55M	949.68M	940.85M	1.14B
Total Liabilities	753.85M	1.04B	1.2B	1.22B
Total Debt	672.43M	933.93M	948.48M	955.36M
Common Stock	294K	268K	227K	221K
Retained Earnings	-2.15B	-1.84B	-1.53B	-1.22B
Comprehensive Income	422K	219K	-4.76M	-1.09M
Shareholders Equity	506.59M	701.3M	562.9M	790.99M
Total Investments	334.56M	453.93M	447.23M	583.67M